Long-term efficacy of doxazosin plus atenolol in the management of severe and sustained arterial hypertension and reversibility of the cardiac damage induced by chronic cathecolamine excess. A case report in a young girl with recurrent, functioning paraganglioma

J Endocrinol Invest. 2004 Sep;27(8):774-7. doi: 10.1007/BF03347522.

Abstract

Herein we report on a young girl with recurrent, functioning paraganglioma of the organ of Zuckerkandl and severe and sustained arterial hypertension (systolic pressure >200, diastolic pressure >120 mmHg); with evidence of cardiac damage induced by chronic cathecolamine excess. She promptly and steadily improved after the institution of doxazosin (6 mg/day) plus atenolol (50 mg bid) treatment. This case demonstrates that a correct therapeutic strategy in the long-term management of patients with inoperable catecholamine-producing neuroendocrine tumors (pheochromocytomas and paragangliomas) can maintain arterial pressure in the normal range and reverse the cardiac damage induced by chronic cathecolamine excess.

MeSH terms

  • 3-Iodobenzylguanidine
  • Adrenergic alpha-Antagonists / therapeutic use*
  • Adrenergic beta-Antagonists / therapeutic use*
  • Atenolol / therapeutic use*
  • Blood Pressure / drug effects
  • Catecholamines / blood
  • Catecholamines / physiology*
  • Child
  • Doxazosin / therapeutic use*
  • Drug Therapy, Combination
  • Electrocardiography / drug effects
  • Female
  • Heart Diseases / drug therapy*
  • Heart Diseases / pathology
  • Heart Neoplasms / diagnostic imaging
  • Heart Neoplasms / drug therapy*
  • Heart Neoplasms / pathology
  • Heart Rate / drug effects
  • Humans
  • Hypertension / drug therapy*
  • Hypertrophy, Left Ventricular / drug therapy
  • Hypertrophy, Left Ventricular / pathology
  • Para-Aortic Bodies / diagnostic imaging*
  • Paraganglioma / complications*
  • Paraganglioma / diagnostic imaging
  • Radionuclide Imaging
  • Radiopharmaceuticals

Substances

  • Adrenergic alpha-Antagonists
  • Adrenergic beta-Antagonists
  • Catecholamines
  • Radiopharmaceuticals
  • 3-Iodobenzylguanidine
  • Atenolol
  • Doxazosin